Urgent.News

What's breaking now, across thousands of outlets.

Business

Greycoat Research Announces Publication of 3,006-Cat Kidney Data Study

Greycoat Research, a company specializing in feline kidney care, announced on Nov. 16 that a study conducted with researchers in South Korea and Japan, analyzing blood test data from 3,006 cats, was published on Oct. 22, 2026, in Frontiers in Veterinary Science, an SCIE-indexed international veterin

On November 16, Greycoat Research, a feline kidney care specialist, released the findings of a comprehensive study involving blood test data from 3,006 cats. This research, published in the SCIE-indexed journal Frontiers in Veterinary Science on October 22, 2026, aimed to better understand the health of cats by examining the relationship between kidney test results, specifically creatinine levels, and other blood test indicators.

The study was a collaborative effort between Greycoat Research and veterinarians Dr. Jae Young Kim from South Korea and Dr. Motoo Kobayashi from Japan. By integrating veterinary clinical expertise with data analysis, the researchers categorized creatinine values into seven ranges and compared various blood test results, including those related to inflammation and anemia, within these ranges.

This approach allowed them to identify patterns and differences among individual cats, revealing that not all indicators followed the same patterns.

The researchers found that kidney markers and other health indicators did not always align, suggesting that a comprehensive assessment of a cat’s health requires considering multiple blood test results alongside kidney markers. This finding underscores the complexity of cat health evaluation and highlights the importance of a multi-faceted approach to diagnosing and treating kidney disease.

In 2025, Greycoat Research also published a related study on the effects of resveratrol supplementation on cats’ blood test results, marking a second consecutive year of SCIE-indexed journal publications in this area. The company is planning to collect more blood test data through collaborations with research partners in South Korea, Japan, and other countries.

This ongoing research aims to verify the study’s findings in a broader dataset and determine which additional tests should be considered when developing personalized care strategies for cats with kidney disease. Dr. Hocheol Shin, the lead researcher, emphasized that this study provides a solid foundation for understanding kidney disease in cats, paving the way for more tailored and effective care approaches for feline patients.

Written by urgent.news from BusinessKorea's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at businesskorea.co.kr →

More in Business

Europe’s moment to lead: Backing research in a global race

Our future depends on choosing to invest in a resilient, competitive, innovative and secure environment in which society can thrive. Our human capital is the foundation of that success, the economic driver of innovation and productivity. Like any source of growth, it requires investment.

More from Monday 16 November →